msrm

🍄 Peter Brandt talks about “magic mushrooms.” What if real mushrooms are already becoming technology?

In crypto, 🍄 is a metaphor for self-deception: when an investor sees only $1 million per BTC and stops noticing the risks.

But in the real world, mushrooms are already biotechnology, new materials, and AI.

Mushrooms Inc. (OTC: MSRM) announced a Proof of Concept for MycoLabX: mycelium films demonstrated a color change when interacting with bacteria. Potential applications include technologies for the early detection of infections, particularly in wound care.

At the same time, the company is developing MycoLab.ai — an AI platform for working with scientific data on mycology.

But DVA reminds you:

Proof of Concept ≠ finished product.
Technology ≠ commercial success.
OTC stock ≠ guaranteed profit.

MSRM is a very small, high-risk company. So we’re watching the facts, not the attractive story: independent validation, partners, funding, and actual commercialization.

🍄 Mushrooms can be technology.
But investors shouldn’t turn into mushrooms themselves.

DVA — facts without hype.

Not financial advice.
Preserving value and time.

#DVA #Biotech #AI #Mycelium #MSRM